gleevec
Generic: imatinib mesylate
Labeler: novartis pharmaceuticals corporationDrug Facts
Product Profile
Brand Name
gleevec
Generic Name
imatinib mesylate
Labeler
novartis pharmaceuticals corporation
Dosage Form
TABLET
Routes
Active Ingredients
imatinib mesylate 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0078-0649
Product ID
0078-0649_cbc7561e-5e16-4e05-9c07-52626c43eafc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021588
Listing Expiration
2027-12-31
Marketing Start
2014-12-23
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00780649
Hyphenated Format
0078-0649
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gleevec (source: ndc)
Generic Name
imatinib mesylate (source: ndc)
Application Number
NDA021588 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 3 BLISTER PACK in 1 CARTON (0078-0649-13) / 10 TABLET in 1 BLISTER PACK (0078-0649-26)
- 30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cbc7561e-5e16-4e05-9c07-52626c43eafc", "openfda": {"unii": ["8A1O1M485B"], "rxcui": ["403878", "403879", "404588", "404589"], "spl_set_id": ["211ef2da-2868-4a77-8055-1cb2cd78e24b"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (0078-0649-13) / 10 TABLET in 1 BLISTER PACK (0078-0649-26)", "package_ndc": "0078-0649-13", "marketing_start_date": "20240301"}, {"sample": false, "description": "30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30)", "package_ndc": "0078-0649-30", "marketing_end_date": "20261231", "marketing_start_date": "20141223"}], "brand_name": "Gleevec", "product_id": "0078-0649_cbc7561e-5e16-4e05-9c07-52626c43eafc", "dosage_form": "TABLET", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "0078-0649", "generic_name": "imatinib mesylate", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gleevec", "active_ingredients": [{"name": "IMATINIB MESYLATE", "strength": "400 mg/1"}], "application_number": "NDA021588", "marketing_category": "NDA", "marketing_start_date": "20141223", "listing_expiration_date": "20271231"}